A Telomere-Targeting Drug Depletes Cancer Initiating Cells and Promotes Anti-Tumor Immunity in Small Cell Lung Cancer

Using preclinical mouse and human derived models, investigators found low intermittent doses of 6-Thio-2’-deoxyguanosine inhibit tumor growth and reduce metastatic burden.